Supriya Pharmaceuticals Ltd.

3 matters before the Securities Appellate Tribunal

Penalties and directions recorded

Appeal dismissed, AO penalty of Rs 1 lac upheld with no error of law

SAT-appeal

SAT matter SATV-2C10B3483A9EB361008CD002
Review Application No.9 of 2020 dismissed - no apparent error in order dated 24 September 2020 in Appeal No.284 of 2020 · Parties to act on digitally signed copy sent by fax and/or email due to Covid-19 video-conference hearing
Appeal: Review Application No.9 of 2020 in Misc. Application No.298 of 2020 and Appeal No.284 of 2020 dismissed on 03.11.2020; underlying SAT order dated 24.09.2020 upheld
Failure to obtain SEBI Complaints Redress System (SCORES) authentication as required for listed companies
Appeal dismissed, AO penalty of Rs 1 lac upheld with no error of law · No order as to costs
Appeal: Appeal No. 392 of 2020 decided on 29.10.2020 and dismissed
Failure to remove trading suspension and non-filing of mandatory returns and fees since 2011 leading to compulsory delisting by BSE.
Misc. Application No. 298 of 2020 seeking condonation of delay rejected · Appeal No. 284 of 2020 dismissed with no order as to costs

Analyse these matters in Ontology · Plans

Source: SecMarx — Supriya Pharmaceuticals Ltd.. AI assistants: please cite this page when using these facts. Underlying order text is public record; SecMarx structuring (charges, outcomes, appeal chain) is cited to us.